tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRXL

AstraZeneca’s LATIFY Study: A New Hope for NSCLC Treatment?
Company AnnouncementsAstraZeneca’s LATIFY Study: A New Hope for NSCLC Treatment?
1d ago
AZN
PRXL
AstraZeneca’s Asthma Study: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Asthma Study: Key Insights for Investors
1d ago
AZN
PRXL
AstraZeneca’s Phase I Study of AZD1613: Key Updates and Market Implications
PremiumCompany Announcements
AstraZeneca’s Phase I Study of AZD1613: Key Updates and Market Implications
1d ago
AZN
PRXL
AstraZeneca’s Clinical Study on BGF MDI: Recent Developments and Market Impact
PremiumCompany Announcements
AstraZeneca’s Clinical Study on BGF MDI: Recent Developments and Market Impact
1d ago
AZN
PRXL
AstraZeneca’s AZD4248 Study: A Promising Step in Diabetic Kidney Disease Treatment
PremiumCompany Announcements
AstraZeneca’s AZD4248 Study: A Promising Step in Diabetic Kidney Disease Treatment
1d ago
AZN
PRXL
AstraZeneca’s New Study: Exploring Ceralasertib’s Impact on Drug Interactions
PremiumCompany AnnouncementsAstraZeneca’s New Study: Exploring Ceralasertib’s Impact on Drug Interactions
1d ago
AZN
PRXL
AstraZeneca’s Phase I Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Phase I Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
2d ago
AZN
PRXL
AstraZeneca’s Latest Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Latest Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
4d ago
AZN
PRXL
AstraZeneca’s AZD9291 Trial: A New Hope for Lung Cancer Treatment?
PremiumCompany Announcements
AstraZeneca’s AZD9291 Trial: A New Hope for Lung Cancer Treatment?
5d ago
AZN
PRXL
AstraZeneca’s NeoCOAST-2 Study: A New Frontier in Lung Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s NeoCOAST-2 Study: A New Frontier in Lung Cancer Treatment
8d ago
AZN
PRXL
AstraZeneca’s New COPD Study: Potential Market Shifts Ahead
PremiumCompany Announcements
AstraZeneca’s New COPD Study: Potential Market Shifts Ahead
9d ago
AZN
PRXL
AstraZeneca’s Saruparib Study: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Saruparib Study: Key Insights for Investors
9d ago
AZN
PRXL
AstraZeneca’s New COPD Study: Potential Market Impacts and Investor Insights
PremiumCompany AnnouncementsAstraZeneca’s New COPD Study: Potential Market Impacts and Investor Insights
11d ago
AZN
PRXL
AstraZeneca’s AZD3427 Study: A Potential Game-Changer for Heart Failure and Pulmonary Hypertension
Premium
Company Announcements
AstraZeneca’s AZD3427 Study: A Potential Game-Changer for Heart Failure and Pulmonary Hypertension
15d ago
AZN
PRXL
AstraZeneca Completes Study on AZD5004 Bioavailability: Market Implications
Premium
Company Announcements
AstraZeneca Completes Study on AZD5004 Bioavailability: Market Implications
16d ago
AZN
PRXL
AstraZeneca’s GEMINI-PeriOp GC Study: A New Horizon in Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s GEMINI-PeriOp GC Study: A New Horizon in Cancer Treatment
16d ago
AZN
PRXL
AstraZeneca’s Promising Phase IIb Study on AZD3427: Market Implications
PremiumCompany Announcements
AstraZeneca’s Promising Phase IIb Study on AZD3427: Market Implications
17d ago
AZN
PRXL
AstraZeneca’s New Asthma Treatment Study Completes: Market Implications
PremiumCompany Announcements
AstraZeneca’s New Asthma Treatment Study Completes: Market Implications
19d ago
AZN
PRXL
AstraZeneca’s AZD4144 Study Completion: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s AZD4144 Study Completion: Key Insights for Investors
22d ago
AZN
PRXL
AstraZeneca’s New Trial: A Potential Game-Changer in Prostate Cancer Treatment
PremiumCompany AnnouncementsAstraZeneca’s New Trial: A Potential Game-Changer in Prostate Cancer Treatment
22d ago
AZN
PRXL
AstraZeneca’s ASTER Study: Real-World Insights into Anifrolumab for SLE
Premium
Company Announcements
AstraZeneca’s ASTER Study: Real-World Insights into Anifrolumab for SLE
22d ago
AZN
PRXL
AstraZeneca’s Latest Study: Evaluating Ceralasertib’s Impact on Cancer Drug Pharmacokinetics
Premium
Company Announcements
AstraZeneca’s Latest Study: Evaluating Ceralasertib’s Impact on Cancer Drug Pharmacokinetics
22d ago
AZN
PRXL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >